Moleculin Biotech Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Dec 23 | BuyUS$129,999 | Walter Klemp | Individual | 12,560.27 | US$10.35 | |
26 Dec 23 | BuyUS$20,000 | Jonathan Foster | Individual | 1,932.4 | US$10.35 | |
26 Dec 23 | BuyUS$10,000 | Robert George | Individual | 966.2 | US$10.35 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 7,000 | 0.246% |
Individual Insiders | 93,278 | 3.28% |
Hedge Funds | 156,000 | 5.48% |
Institutions | 158,140 | 5.56% |
General Public | 2,430,109 | 85.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
156,000 | US$383.8k | 5.05% | 0.01% | |||
84,418 | US$207.7k | 12.1% | no data | |||
72,935 | US$179.4k | 29.6% | no data | |||
33,754 | US$83.0k | 0% | no data | |||
19,756 | US$48.6k | 19% | no data | |||
12,475 | US$30.7k | 0.02% | no data | |||
11,363 | US$28.0k | 0% | no data | |||
8,001 | US$19.7k | 0% | no data | |||
7,000 | US$17.2k | 0% | no data | |||
3,334 | US$8.2k | 0% | no data | |||
1,995 | US$4.9k | 221% | no data | |||
1,367 | US$3.4k | 99.6% | no data | |||
979 | US$2.4k | 0.1% | no data | |||
426 | US$1.0k | 0.71% | no data | |||
366 | US$900.6 | 1.1% | no data | |||
89 | US$219.0 | 0% | no data | |||
42 | US$103.6 | 0% | no data | |||
34 | US$84.0 | 0% | no data | |||
25 | US$61.6 | 257% | no data | |||
23 | US$56.7 | 0% | no data | |||
17 | US$42.0 | 6.25% | no data | |||
10 | US$24.5 | 0% | no data | |||
6 | US$14.7 | -14.3% | no data | |||
3 | US$7.7 | 0% | no data |